Peer Review reports
From: Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation
| Original Submission | ||
|---|---|---|
| 20 Jan 2023 | Submitted | Original manuscript |
| 12 Mar 2023 | Reviewed | Reviewer Report - Jasvinder Singh |
| 13 Mar 2023 | Reviewed | Reviewer Report |
| 30 Apr 2023 | Author responded | Author comments - Lin Miao |
| Resubmission - Version 2 | ||
| 30 Apr 2023 | Submitted | Manuscript version 2 |
| 5 May 2023 | Author responded | Author comments - Lin Miao |
| Resubmission - Version 3 | ||
| 5 May 2023 | Submitted | Manuscript version 3 |
| Publishing | ||
| 12 May 2023 | Editorially accepted | |
| 23 May 2023 | Article published | 10.1186/s12885-023-10954-8 |
You can find further information about peer review here.